Evidence map›Paper›PMID 26300552›Full record

ArticleProtein science : a publication of the Protein Society2015

Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.

Marta Marin-Argany, Jofre Güell-Bosch, Luis M Blancas-Mejía, Sandra Villegas, Marina Ramirez-Alvarado

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Role of complementarity-determining regions 1 and 3 in pathologic amyloid formation by human immunoglobulin κ1 light chains.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2023
    Article
  7. Article
  8. Review
  9. Cu(II) Binding Increases the Soluble Toxicity of Amyloidogenic Light Chains.International journal of molecular sciences · 2022
    Article
  10. Review
  11. Article
  12. Early events in light chain aggregation at physiological pH reveal new insights on assembly, stability, and aggregate dissociation.Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2021
    Article
  13. Article
  14. Review
  15. Article
  16. Immunoglobulin light chain amyloid aggregation.Chemical communications (Cambridge, England) · 2018
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Marta Marin-ArganyDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, 55905.
Jofre Güell-BoschDepartament De Bioquímica I Biologia Molecular, Unitat De Bioquímica De Biociències, Universitat Autònoma De Barcelona, Cerdanyola Del Vallès, 08193, Spain.
Luis M Blancas-MejíaDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, 55905.
Sandra VillegasDepartament De Bioquímica I Biologia Molecular, Unitat De Bioquímica De Biociències, Universitat Autònoma De Barcelona, Cerdanyola Del Vallès, 08193, Spain.
Marina Ramirez-AlvaradoDepartment of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, 55905.
Mayo Clinic · USUniversitat Autònoma de Barcelona · ES

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
Mechanisms of Aggregation in Light Chain AmyloidosisR01GM071514 · NIGMS · MAYO CLINIC ROCHESTER · PI RAMIREZ-ALVARADO, MARINA · 2006 to 2014
$2.8M
NCI NIH HHS P30 CA015083NIGMS NIH HHS R01 GM 071514NIGMS NIH HHS R01 GM071514PCORI FIS-PI13-01330PHS HHS SGR14-GRC-00885
6 · The paper itself

Abstract

Light chain (AL) amyloidosis is an incurable human disease, where the amyloid precursor is a misfolding-prone immunoglobulin light-chain. Here, we identify the role of somatic mutations in the structure, stability and in vitro fibril formation for an amyloidogenic AL-12 protein by restoring four nonconservative mutations to their germline (wild-type) sequence. The single restorative mutations do not affect significantly the native structure, the unfolding pathway, and the reversibility of the protein. However, certain mutations either decrease (H32Y and H70D) or increase (R65S and Q96Y) the protein thermal stability. Interestingly, the most and the least stable mutants, Q96Y and H32Y, do not form amyloid fibrils under physiological conditions. Thus, Q96 and H32 are key residues for AL-12 stability and fibril formation and restoring them to the wild-type residues preclude amyloid formation. The mutants whose equilibrium is shifted to either the native or unfolded states barely sample transient partially folded states, and therefore do not form fibrils. These results agree with previous observations by our laboratory and others that amyloid formation occurs because of the sampling of partially folded states found within the unfolding transition (Blancas-Mejia and Ramirez-Alvarado, Ann Rev Biochem 2013;82:745-774). Here we provide a new insight on the AL amyloidosis mechanism by demonstrating that AL-12 does not follow the established thermodynamic hypothesis of amyloid formation. In this hypothesis, thermodynamically unstable proteins are more prone to amyloid formation. Here we show that within a thermal stability range, the most stable protein in this study is the most amyloidogenic protein.

Indexed as

Amino Acid SequenceAmyloidHumansImmunoglobulin Light ChainsMolecular Sequence DataMutationProtein FoldingProtein StabilitySequence AlignmentThermodynamicsAmyloidImmunoglobulin Light Chainsaggregationimmunoglobulin foldlight chain amyloidosisprotein misfoldingsomatic mutationsthermodynamics

Identifiers

PMID26300552
PMCPMC4622216
OpenAlexW1954766381

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.